Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
11151
Lantern Pharma
LTRN
$13.6M
| $120K | ﹤0.01% |
37,587
+35,434
| +1,646% | +$121K |
2024 Q3
1 quarter
|
|
11152
PUT
Resideo Technologies
REZI
$2.67B
| $120K | ﹤0.01% |
5,200
-2,100
| -29% | -$49.2K |
2022 Q3
9 quarters
|
|
11153
PUT
AMC Global Media
AMCX
$443M
| $120K | ﹤0.01% |
12,100
-5,500
| -31% | -$48.6K |
2019 Q4
20 quarters
|
|
11154
KORU Medical Systems
KRMD
$138M
| $120K | ﹤0.01% |
31,111
-82,198
| -73% | -$267K |
2022 Q4
8 quarters
|
|
11155
CALL
Zegna
ZGN
$3.28B
| $120K | ﹤0.01% |
14,500
-27,500
| -65% | -$225K |
2023 Q1
7 quarters
|
|
|
DDL
11156
CALL
Dingdong
DDL
$453M
| $120K | ﹤0.01% |
36,500
+36,300
| +18,150% | +$140K |
2024 Q3
1 quarter
|
|
11157
DMC Global
BOOM
$119M
| $120K | ﹤0.01% |
16,280
-17,030
| -51% | -$161K |
2019 Q3
21 quarters
|
|
11158
CALL
Invesco S&P 500 Pure Growth ETF
RPG
$1.97B
| $120K | ﹤0.01% |
2,900
+2,700
| +1,350% | +$112K |
2023 Q3
5 quarters
|
|
|
CLYM
11159
Climb Bio
CLYM
$615M
| $120K | ﹤0.01% |
+66,472
| New | +$241K |
2024 Q4
0 quarters
|
|
11160
PUT
Wheels Up
UP
$137M
| $120K | ﹤0.01% |
3,625
+2,155
| +147% | +$90.7K |
2021 Q3
13 quarters
|
|
11161
CALL
Liquidity Services
LQDT
$1.29B
| $119K | ﹤0.01% |
3,700
-3,100
| -46% | -$78.6K |
2022 Q4
8 quarters
|
|
11162
Creative Realities
CREX
$32.7M
| $119K | ﹤0.01% |
48,764
+17,238
| +55% | +$63.6K |
2024 Q2
2 quarters
|
|
11163
PUT
Four Corners Property Trust
FCPT
$2.31B
| $119K | ﹤0.01% |
4,400
-2,900
| -40% | -$82.7K |
2024 Q1
3 quarters
|
|
11164
CALL
Suzano
SUZ
$10.4B
| $119K | ﹤0.01% |
11,800
-9,600
| -45% | -$98.3K |
2024 Q1
3 quarters
|
|
11165
CALL
Kura Oncology
KURA
$949M
| $119K | ﹤0.01% |
13,700
+4,000
| +41% | +$57.6K |
2020 Q2
18 quarters
|
|
11166
PUT
Larimar Therapeutics
LRMR
$286M
| $119K | ﹤0.01% |
30,800
+1,400
| +5% | +$9.24K |
2023 Q1
7 quarters
|
|
11167
PUT
PRA Group
PRAA
$764M
| $119K | ﹤0.01% |
5,700
-10,300
| -64% | -$220K |
2022 Q3
9 quarters
|
|
11168
PUT
Tecnoglass Holdings
TGLS
$1.66B
| $119K | ﹤0.01% |
1,500
-10,200
| -87% | -$776K |
2021 Q3
13 quarters
|
|
11169
PUT
Immunome
IMNM
$2.25B
| $119K | ﹤0.01% |
11,200
+2,800
| +33% | +$33.8K |
2023 Q1
7 quarters
|
|
11170
PUT
Clarivate
CLVT
$940M
| $119K | ﹤0.01% |
23,400
+7,500
| +47% | +$43.2K |
2021 Q1
15 quarters
|
|
|
BLDP
11171
PUT
Ballard Power Systems
BLDP
$702M
| $119K | ﹤0.01% |
71,600
+37,900
| +112% | +$59K |
2019 Q1
23 quarters
|
|
|
DGXX
11172
Digi Power X Inc
DGXX
$339M
| $119K | ﹤0.01% |
79,150
+8,499
| +12% | +$13.9K |
2024 Q3
1 quarter
|
|
11173
CALL
Gaia
GAIA
$35.6M
| $119K | ﹤0.01% |
+26,400
| New | +$144K |
2024 Q4
0 quarters
|
|
11174
CALL
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.79B
| $119K | ﹤0.01% |
+5,500
| New | +$120K |
2024 Q4
0 quarters
|
|
11175
SCYNEXIS
SCYX
$47.6M
| $118K | ﹤0.01% |
+12,242
| New | +$127K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.